Improving Resilience in Adults 65 and Older Receiving Chemotherapy Using Electronic Frailty Index-Guided Supportive Care

What this Trial Is About

Researchers are evaluating ways to improve resilience in adults aged 65 and older who have cancer and are receiving chemotherapy. The study focuses on patients who are considered pre-frail or frail based on the Electronic Frailty Index eFI. The goal is to better understand the specific needs of these older adults during chemotherapy and to tailor care plans accordingly. Participants will undergo a baseline assessment before starting chemotherapy, which includes measuring their frailty status. They will receive education on their results and be offered referrals for supportive care designed to reduce chemotherapy toxicity. For 12 weeks, participants will complete weekly symptom reports through electronic surveys and phone calls with a research nurse. After the 12-week period, follow-up assessments will be conducted, and some participants and their providers will be invited to interviews to share feedback on the intervention. Throughout the study, participants will be monitored for recruitment and retention rates, as well as completion of weekly symptom assessments. Researchers will track hospital admissions and emergency department visits over the 12 weeks. This study involves regular patient-reported outcomes and supportive care interventions, aiming to enhance how older adults respond to chemotherapy. The total participation lasts at least 12 weeks after chemotherapy initiation, with ongoing feedback collection from some participants and providers.

Resilience Enhancement Using Electronic Frailty Index-Directed Care Pathway